Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Kongnakorn
Estimating the Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban in Non-Valvular Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Apixaban for Stroke Prevention in Non-Valvular Atrial Fibrillation in Saudi Arabia
Annals of Saudi Medicine
Medicine
Effect and Risk of Novel Oral Anticoagulants Versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
Journal of Cardiology
Cardiovascular Medicine
Cardiology
The Economic Impact Associated With Cerebrovascular Events Related to Non-Valvular Atrial Fibrillation (NVAF) in Italy: The Role of Apixaban
Farmeconomia. Health economics and therapeutic pathways
Clinical Characteristics and 12-Month Outcomes of Patients With Valvular and Non-Valvular Atrial Fibrillation in Kenya
PLoS ONE
Multidisciplinary
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation
American Journal of Cardiology
Cardiovascular Medicine
Cardiology
Pcv116 - Discontinuation and Health Care Resource Utilisation in Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Warfarin in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Thromboembolic Events in Paroxysmal vs. Permanent Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Suboptimal Oral Anticoagulant Treatment Among Chinese Non-Valvular Atrial Fibrillation Patients: The Nanchang Atrial Fibrillation Project
Archives of Medical Science
Medicine
